Literature DB >> 35690686

Modulatory effect of long-term treatment with escitalopram and clonazepam on the expression of anxiety-related neuropeptides: neuromedin U, neuropeptide S and their receptors in the rat brain.

Aneta Piwowarczyk-Nowak1, Artur Pałasz2, Katarzyna Bogus3, Marek Krzystanek4, Iwona Błaszczyk3, John J Worthington5, Aniela Grajoszek6.   

Abstract

BACKGROUND: Newly identified multifunctional peptidergic modulators of stress responses: neuromedin U (NMU) and neuropeptide S (NPS) are involved in the wide spectrum of brain functions. However, there are no reports dealing with potential molecular relationships between the action of diverse anxiolytic or antidepressant drugs and NMU and NPS signaling in the brain. The present work was therefore focused on local expression of the aforementioned stress-related neuropeptides in the rat brain after long-term treatment with escitalopram and clonazepam.
METHODS: Studies were carried out on adult, male Sprague-Dawley rats that were divided into 3 groups: animals injected with saline (control) and experimental individuals treated with escitalopram (at single dose 5 mg/kg daily), and clonazepam (at single dose 0.5 mg/kg). All individuals were sacrificed under anaesthesia and the whole brain excised. Total mRNA was isolated from homogenized samples of amygdala, hippocampus, hypothalamus, thalamus, cerebellum and brainstem. Real time-PCR method was used for estimation of related NPS, NPS receptor (NPSR), NMU, NMU and receptor 2 (NMUR2) mRNA expression. The whole brains were also sliced for general immunohistochemical assessment of the neuropeptides expression.
RESULTS: Chronic administration of clonazepam resulted in an increase of NMU mRNA expression and formation of NMU-expressing fibers in the amygdala, while escitalopram produced a significant decrease in NPSR mRNA level in hypothalamus. Long-term escitalopram administration affects the local expression of examined neuropeptides mRNA in a varied manner depending on the brain structure.
CONCLUSIONS: Pharmacological effects of escitalopram may be connected with local at least partially NPSR-related alterations in the NPS/NMU/NMUR2 gene expression at the level selected rat brain regions. A novel alternative mode of SSRI action can be therefore cautiously proposed.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Clonazepam; Escitalopram; Neuromedin U; Neuropeptide S; Neuropeptides

Mesh:

Substances:

Year:  2022        PMID: 35690686     DOI: 10.1007/s11033-022-07578-9

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.742


  24 in total

1.  Neuropeptide S stimulates dopaminergic neurotransmission in the medial prefrontal cortex.

Authors:  Wei Si; Leah Aluisio; Naoe Okamura; Stewart D Clark; Ian Fraser; Steven W Sutton; Pascal Bonaventure; Rainer K Reinscheid
Journal:  J Neurochem       Date:  2010-08-30       Impact factor: 5.372

2.  Neuropeptide S Induces Acute Anxiolysis by Phospholipase C-Dependent Signaling within the Medial Amygdala.

Authors:  Thomas Grund; Inga D Neumann
Journal:  Neuropsychopharmacology       Date:  2017-08-14       Impact factor: 7.853

3.  Anatomical characterization of the neuropeptide S system in the mouse brain by in situ hybridization and immunohistochemistry.

Authors:  Stewart D Clark; Dee M Duangdao; Stefan Schulz; Li Zhang; Xiaobin Liu; Yan-Ling Xu; Rainer K Reinscheid
Journal:  J Comp Neurol       Date:  2011-07-01       Impact factor: 3.215

4.  Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S-expressing neurons in the rat brain.

Authors:  Yan-Ling Xu; Christine M Gall; Valerie R Jackson; Olivier Civelli; Rainer K Reinscheid
Journal:  J Comp Neurol       Date:  2007-01-01       Impact factor: 3.215

5.  Neurotransmissions of antidepressant-like effects of neuromedin U-23 in mice.

Authors:  Masaru Tanaka; Gyula Telegdy
Journal:  Behav Brain Res       Date:  2013-11-13       Impact factor: 3.332

6.  Molecular dissection of G protein preference using Gsalpha chimeras reveals novel ligand signaling of GPCRs.

Authors:  Shih-Han Hsu; Ching-Wei Luo
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-07-24       Impact factor: 4.310

7.  Neuromedin U and Neuromedin U receptor-2 expression in the mouse and rat hypothalamus: effects of nutritional status.

Authors:  E S Graham; Y Turnbull; P Fotheringham; K Nilaweera; J G Mercer; P J Morgan; P Barrett
Journal:  J Neurochem       Date:  2003-12       Impact factor: 5.372

Review 8.  Neuropeptide S: a transmitter system in the brain regulating fear and anxiety.

Authors:  Hans-Christian Pape; Kay Jüngling; Thomas Seidenbecher; Jörg Lesting; Rainer K Reinscheid
Journal:  Neuropharmacology       Date:  2009-06-10       Impact factor: 5.250

9.  Brain region-specific neuromedin U signalling regulates alcohol-related behaviours and food intake in rodents.

Authors:  Daniel Vallöf; Aimilia Lydia Kalafateli; Elisabet Jerlhag
Journal:  Addict Biol       Date:  2019-05-08       Impact factor: 4.280

10.  Neuropeptide S- and Neuropeptide S receptor-expressing neuron populations in the human pons.

Authors:  Csaba Adori; Swapnali Barde; Nenad Bogdanovic; Mathias Uhlén; Rainer R Reinscheid; Gabor G Kovacs; Tomas Hökfelt
Journal:  Front Neuroanat       Date:  2015-09-25       Impact factor: 3.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.